合理的HIV免疫原设计以准特定的生殖线B细胞受体
Joseph Jardine1, Jean-Philippe Julien, Sergey Menis
1Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
Science (New York, N.Y.)
|March 30, 2013
概括
开发一种HIV-1疫苗至关重要. 研究人员设计了一种新型免疫原体 (eOD-GT6),可以成功激活B细胞,显示出疫苗产生广泛中和抗体 (bNAbs) 的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 结构生物学 结构生物学
背景情况:
- 通过疫苗接种诱导针对HIV-1的广泛中和抗体 (bNAbs) 仍然是一个重大的全球卫生挑战.
- 针对HIV gp120 CD4结合部位的VRC01类bNAbs具有强效,但尚未通过免疫成功获得.
- 野生类型的HIV gp120蛋白对VRC01类bNAbs的生殖线前体有较低的亲和力,这阻碍了它们作为有效的免疫原体的使用.
研究的目的:
- 设计一种能够启动VRC01类广泛中和抗体反应的新型免疫原体.
- 开发一种候选疫苗,针对强大的HIV-1中和抗体的生殖线前体.
主要方法:
- 利用计算引导的体外查来设计一个向生殖线的gp120外域免疫原体.
- 使用晶体学描述了工程免疫原与VRC01类bNAbs及其生殖线前体的结合.
- 将免疫原多元化成纳米粒子 (eOD-GT6) 用于疫苗应用.
主要成果:
- 工程免疫原体 (eOD-GT6) 证明与多个VRC01类bNAbs及其生殖线前体结合.
- 结晶学分析阐明了生殖系结合相互作用.
- 多元化eOD-GT6纳米粒子在体外成功激活了生殖细胞和成熟的VRC01类B细胞.
结论:
- eOD-GT6纳米粒子免疫原体显示出显著的希望,作为一种用于诱导VRC01类bNAbs针对HIV-1的疫苗首选.
- 采用的生殖线向策略可能适用于开发针对其他表位和病原体的疫苗.
- 这项工作代表了向有效的HIV-1疫苗迈出的关键一步.
相关概念视频
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...